all island point of sale inc.

258-11 hillside ave, store 1
floral park, new york 11004

NYS Entity Status
ACTIVE

NYS Filing Date
MARCH 27, 2014

NYS DOS ID#
4552063

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - ALL ISLAND POINT OF SALE INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • SUMMER FIRSTS | Brooklyn: Finding Alchemy and Art on a Coney Island Scary Ride
    By FRANCINE PROSE - Wednesday Aug 2, 2017

    For Francine Prose, an amusement-park trip as a young girl led to a ride on the Spook-a-Rama and later to a prized Diane Arbus photo of the same ride.

    Source: NYT > Home Page
  • New York Today: New York Today: New Subway Clocks
    By JONATHAN WOLFE - Monday Aug 7, 2017

    Monday: Rolling out new subway clocks, the Corkscrew Theater Festival, and National Lighthouse Day.

    Source: NYT > Home Page
  • Under the Stars and Quilts, With Randalls Island as Her Stage
    By GIA KOURLAS - Friday Aug 11, 2017

    For her newest performance project, the dance artist Emily Johnson will gather 300 people for an all-night event.

    Source: NYT > Home Page
  • For 18 Hours, Cabbie Sat Dead in Front Seat
    By KIM BARKER - Monday Aug 14, 2017

    A driver parked his taxi to take a break in SoHo. He died behind the wheel. Then, for nearly a day, New Yorkers went about their lives — just feet from his body.

    Source: NYT > Home Page
  • Sunday Routine: How Helen Uffner, Vintage Clothing Expert, Spends Her Sundays
    By ABIGAIL MEISEL - Friday Aug 11, 2017

    She’s found retro outfits for Meryl Streep and Kate Winslet. On Sundays, the period clothing specialist visits flea markets and estate sales.

    Source: NYT > Home Page
  • Abbvie’s hep C drug pricing threatens Gilead’s dominance
    By Max Nisen - Tuesday Aug 8, 2017

    Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.

    Source: SFGATE.com: Business and Technology News
all island point of sale inc floral park ny